MedTrace Logo

Access to Resources for Patients With PTEN Hamartoma Tumor Syndrome

NCT03680924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2019-10-16

No results posted yet for this study

Summary

The purpose of this study is to gain a better understanding of access to clinical and research resources for families of children affected with a phosphatase and tensin homology (PTEN) mutation. Ultimately, the researchers hope to be able to use this information to develop a standard of care for affected individuals and their family members. Family members/legal guardians of an individual with a PTEN mutation enrolled in the Rare Diseases Clinical Research Network (RDCRN) Contact Registry will be invited via email to participate in this study.

Conditions

  • PTEN Gene Mutation

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-11
Primary Completion
2019-04-01
Completion
2019-09-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03680924 on ClinicalTrials.gov